Auxetic materials have recently attracted interest in the field of crashworthiness thanks to their peculiar negative Poisson ratio, leading to densification under compression and potentially being the basis of superior behavior upon impact with respect to conventional cellular cores or standard solutions. However, the empirical demonstration of the applicability of auxeticity under impact is limited for most known geometries. As such, the present work strives to advance the investigation of the impact behavior of auxetic meta-materials: first by selecting and testing representative specimens, then by proceeding with an experimental and numerical study of repeated impact behavior and penetration resistance, and finally by proposing a new design of a metallic auxetic absorber optimized for additive manufacturing and targeted at high-performance crash applications.

Osteosarcopenia is an emerging clinical condition highly prevalent in the older people. Affected subjects due to their intrinsic skeletal fragility and propensity to falls are at elevated risk of hip fractures which can increase morbidity and mortality. Strategies for attenuating the impact of predisposing factors on hip fractures are not yet well defined and should derive from multidisciplinary care and collaborations. Our aim was to narratively review available data on the preventive role of vitamin D and hip protectors on hip fractures in older patients with sarcopenia. Older subjects are at high risk of vitamin D deficiency and of falls due to several concomitant factors besides osteosarcopenia. Vitamin D protective actions against hip fractures may be mediated by both skeletal (increased mineralization) and extra-skeletal (reduced risk of falls) actions. Hip protectors may act downstream attenuating the effects of falls although their use is still not yet enough widespread due to the suboptimal compliance obtained by traditional hard devices. Concomitant use of vitamin D and hip protectors may represent an effective strategy in the prevention of hip fractures which need to be tested in ad hoc designed clinical trials.